Merz, M., Jauch, A., Hielscher, T., Bochtler, T., Schönland, S., Seckinger, A., … Goldschmidt, H. (2018). Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma. Blood Advances, 2(1), 1-9. https://doi.org/10.1182/bloodadvances.2017013334 (Original work published 2018)

Breitkreutz, I., Podar, K., -Vazquez, F. , V, Wilhelm, S., Hayden, P., Anderson, K., & Raab, M. (2018). The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma. Annals of Hematology. https://doi.org/10.1007/s00277-018-3237-5 (Original work published 2018)